Wells Fargo & Company Lowers Molina Healthcare (NYSE:MOH) Price Target to $410.00

Molina Healthcare (NYSE:MOH) had its price target decreased by research analysts at Wells Fargo & Company from $440.00 to $410.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective points to a potential upside of 8.88% from the stock’s current price.

A number of other equities research analysts have also recently weighed in on MOH. UBS Group increased their price target on Molina Healthcare from $350.00 to $380.00 and gave the company a “neutral” rating in a research note on Thursday, December 21st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 8th. Bank of America cut Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price target on the stock. in a report on Thursday, March 28th. Finally, Barclays began coverage on Molina Healthcare in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 price objective for the company. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $393.09.

Molina Healthcare Trading Down 0.1 %

MOH stock opened at $376.57 on Monday. Molina Healthcare has a twelve month low of $266.35 and a twelve month high of $423.92. The company has a market cap of $22.06 billion, a P/E ratio of 20.05, a PEG ratio of 1.06 and a beta of 0.47. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. The business has a fifty day moving average of $395.00 and a 200-day moving average of $370.45.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share for the quarter, topping the consensus estimate of $4.31 by $0.07. The company had revenue of $9.05 billion for the quarter, compared to analyst estimates of $8.35 billion. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the business posted $4.10 earnings per share. As a group, equities research analysts expect that Molina Healthcare will post 23.62 EPS for the current year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now owns 11,207 shares in the company, valued at approximately $4,494,567.35. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock valued at $6,472,517 over the last 90 days. 1.11% of the stock is owned by insiders.

Institutional Trading of Molina Healthcare

Institutional investors have recently added to or reduced their stakes in the business. Annis Gardner Whiting Capital Advisors LLC bought a new position in Molina Healthcare in the third quarter valued at about $30,000. ST Germain D J Co. Inc. bought a new stake in shares of Molina Healthcare in the 2nd quarter worth about $33,000. McIlrath & Eck LLC bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $34,000. Coppell Advisory Solutions Corp. bought a new stake in shares of Molina Healthcare during the fourth quarter worth $34,000. Finally, VisionPoint Advisory Group LLC grew its stake in Molina Healthcare by 105.6% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.